Pilot Launch You have early access to the Barinhall Compliance Intelligence Portal. Coverage and features are expanding weekly. Share feedback →
← Back to Feed
View source document ↗
T4 SEC Medium Confidence Proposed Rule

SEC Proposes Amendments to Exchange Act Rule 15c2-11

Regulatory clarification to limit Rule 15c2-11 scope to equity securities only

MINIMAL
Impact Level
Top: compliance (2)

Classification

Regulatory Program
Securities Trading - OTC Markets
Doc Type
Proposed Rule
Effective Date
Days to Action
Comment Deadline
Published

Urgency Basis

Proposed rule with 60-day comment period, no immediate compliance obligations

Operational Context

Flags
Legal Review Required
Affected Functions
Trading Operations Compliance Legal
Institution Applicability
Broker-Dealers Otc Market Makers Securities Trading Firms

Impact by Category

Compliance
2
Operational
1
Data Governance
0
Model Risk
0
Reporting & Disclosure
1
Capital & Liquidity
0
Consumer Protection
1
Third-Party Risk
0

Key Requirements

- Review current OTC quotation practices for compliance with clarified rule scope - Ensure quotation and market-making activities align with equity securities limitation - Update internal procedures to reflect rule clarification - Monitor comment period and potential final rule changes

Scoring Rationale

Low impact regulatory clarification that narrows existing rule scope to equity securities. Minimal operational changes required as most institutions likely already understood this limitation. Primary impact on broker-dealers active in OTC markets.

Scored: 2026-06-02T18:03:06.816Z Model: claude-sonnet-4-20250514 Confidence: Medium Aggregate Score: 1.0
AI Analysis Disclosure — This record, including its scores, impact assessments, and Advisory Assessment (impact, risk, and recommended actions), was generated by an AI model and may contain errors or omissions. The Advisory Assessment is a starting point for analysis, not a substitute for professional judgment. Effective dates, applicability determinations, impact assessments, and any recommended actions should be independently verified against primary regulatory source documents and reviewed by qualified compliance or legal personnel before taking compliance action. This output does not constitute legal or compliance advice.